These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32761340)

  • 1. The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia.
    Hefter H; Samadzazeh S; Rosenthal D
    J Neurol; 2021 Jan; 268(1):206-213. PubMed ID: 32761340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
    Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.
    Moll M; Rosenthal D; Hefter H
    Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia.
    Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP
    Technol Health Care; 2024; 32(4):2421-2430. PubMed ID: 38073352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.
    Marciniec M; Szczepańska-Szerej A; Papuć E; Rejdak K
    Int J Neurosci; 2022 Oct; 132(10):1026-1030. PubMed ID: 33295845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance study.
    Jost WH; Schramm A; Müngersdorf M; Stenner A; Schwingenschuh P; Maisonobe P; Koch M; Haslinger B
    J Neurol Sci; 2019 Apr; 399():44-50. PubMed ID: 30771702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Interplay between the Clinical and Presumed Effect of Botulinum Injections for Cervical Dystonia: A Pilot Study.
    Hefter H; Samadzadeh S
    Toxins (Basel); 2023 Sep; 15(10):. PubMed ID: 37888623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis.
    Hefter H; Spiess C; Rosenthal D
    J Neural Transm (Vienna); 2014 May; 121(5):513-9. PubMed ID: 24311063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
    Marciniec M; Szczepańska-Szerej A; Rejdak K
    Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study.
    Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
    Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056396
    [No Abstract]   [Full Text] [Related]  

  • 11. Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.
    Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
    J Neurol Sci; 2020 Sep; 416():117015. PubMed ID: 32682125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany.
    Samadzadeh S; Brauns R; Rosenthal D; Hefter H
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33573065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study.
    Hefter H; Schomaecker I; Schomaecker M; Ürer B; Brauns R; Rosenthal D; Albrecht P; Samadzadeh S
    Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.
    Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
    J Neurol; 2019 Dec; 266(12):3038-3046. PubMed ID: 31501975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA.
    Hefter H; Samadzadeh S; Moll M
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33121133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
    Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
    J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study).
    Tyślerowicz M; Dulski J; Gawryluk J; Sławek J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A and cervical dystonia: a seven-year follow-up.
    Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC
    Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle.
    Wöllner J; Weise D; Leplow B
    Brain Behav; 2021 Mar; 11(3):e02023. PubMed ID: 33403834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.